Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-24-007612

Chief Executive Officer gave up 61,371 shares (to pay taxes)

  • Chief Executive Officer acquired 245,080 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

COATS LONNEL · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-28 Exercise or conversion : show line 1 in the form +33,333 947,692 D
2024-02-28 Exercise or conversion : show line 2 in the form +91,364 1,039,056 D
2024-02-28 Exercise or conversion : show line 3 in the form +120,383 1,159,439 D
2024-02-28 Shares withheld for taxes : show line 4 in the form −61,371 $2.62 $160,792 1,098,068 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-28 Exercise or conversion : show line 5 in the form Restricted Stock Units −33,333 0 D
2024-02-28 Exercise or conversion : show line 6 in the form Restricted Stock Units −91,364 91,363 D
2024-02-28 Exercise or conversion : show line 7 in the form Restricted Stock Units −120,383 240,767 D
Loading xslF345X05/form4.xml…